Clinical trials and evidence
Clinical trials and real-world evidence support evidence-based medicine in healthcare, playing a pivotal role in validating and advancing medical treatments and interventions. Clinical trials assess the efficacy and safety of new drugs and therapies, with real-world evidence providing data to inform clinical and regulatory decisions based on empirical data.
Top Stories
-
Podcast
18 Sep 2024
Exploring chronic disease management trends, strategies
Chronic disease management and prevention strategies are of increasing importance as chronic conditions increase in prevalence. Continue Reading
-
News
26 Aug 2024
Long COVID effects in adolescents, young children vary
NIH-funded research through the RECOVER initiative revealed that long COVID symptoms among pediatric patients varied from sleepiness to headaches, underscoring vaccine importance. Continue Reading
-
News
19 Oct 2020
Half of Black Americans Would Not Get the COVID-19 Vaccine
Black Americans would not even get the COVID-19 vaccine even if it was approved by the FDA and free, underscoring longstanding racial disparities in healthcare, according to a new report. Continue Reading
-
News
19 Oct 2020
Roche Developing High-Volume COVID-19 Antigen Testing Product
The new COVID-19 antibody test will run on all Roche cobas e immunochemistry analyzers, which are widely available around the world. Continue Reading
-
News
15 Oct 2020
AstraZeneca’s COVID-19 Antibody Advances into Phase 3 Trials
The two trials will enroll over 6,000 adults to uncover the safety and efficiency of the company’s COVID-19 antibody treatment. Continue Reading
-
News
15 Oct 2020
Bristol Myers Squibb’s MS Drug Helps Ulcerative Colitis Patients
Both primary and all key secondary efficacy endpoints showed statistically significant improvements with the MS drug versus placebo at Week 10 and Week 52. Continue Reading
-
News
13 Oct 2020
Johnson & Johnson Pauses COVID-19 Vaccine Clinical Trial
The company announced that it paused the Phase 3 COVID-19 vaccine clinical trial due to an unexplained illness. Continue Reading
-
News
13 Oct 2020
Pfizer Doses First Patient in Study on Hemophilia A Gene Therapy
Data from the Phase 3 lead-in study of the gene therapy for moderate to severe hemophilia A patients will provide a baseline for patients evaluated in the Phase 3 study. Continue Reading
-
News
12 Oct 2020
COVID-19 Antibody Cocktail Reduces Viral Levels, Regeneron Says
The COVID-19 antibody cocktail, a combination of two monoclonal antibodies designed to block infectivity of SARS-COV-2, was most effective in patients who had not mounted their own immune response, initial clinical trial data shows. Continue Reading
-
News
08 Oct 2020
GSK, Vir Biotechnology Expand Phase 3 Study of COVID-19 Antibody
The global expansion of the study will reach sites in North America, South America, and Europe to evaluate the COVID-19 antibody treatment in patients who are at high risk of hospitalization. Continue Reading
-
News
05 Oct 2020
Abbott Enrolls First Patient in Spinal Cord Stimulation Study
The study will uncover if Abbott’s BurstDR spinal cord stimulation therapy helps patients who have chronic low back pain with limited surgical options. Continue Reading
-
News
01 Oct 2020
Older Adults Likely to be Excluded from COVID-19 Vaccine Trials
Although older adults account for nearly 30 to 40 percent of coronavirus cases, they are excluded from 100 percent of COVID-19 vaccine trials. Continue Reading
-
News
01 Oct 2020
ViiV Healthcare Launches Injectable HIV Treatment Study
The study aims to find the most practical and efficient ways to implement an injectable HIV treatment regimen. Continue Reading
-
News
30 Sep 2020
Early Data Shows Promise for Johnson & Johnson’s COVID-19 Vaccine
Positive results from an ongoing Phase 1/2a clinical trial supports further clinical development of Johnson & Johnson’s investigational COVID-19 vaccine candidate, Ad26.COV2.S. Continue Reading
-
News
29 Sep 2020
Bristol Myers Squibb Reports Breakthrough with Immunotherapy Opdivo
The immunotherapy met primary endpoints of disease-free survival in both all randomized patients and in patients whose tumor cells expressed PD-L1 greater than one percent. Continue Reading
-
News
24 Sep 2020
J&J Initiates Global Phase 3 Clinical Trial for COVID-19 Vaccine
The Phase 3 trial of the COVID-19 vaccine is based on positive results from a Phase 1/2a study, which showed that safety and immunogenicity were supportive of further development. Continue Reading
-
News
22 Sep 2020
Roche Launches Quantitative COVID-19 Antibody Test
Roche’s improves its previous COVID-19 antibody test, which can now more accurately quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus. Continue Reading
-
News
22 Sep 2020
Just Half of Americans Would Get a COVID-19 Vaccine If Ready Today
The likelihood of receiving a COVID-19 vaccine has greatly declined across all political and demographic groups, largely due to concerns regarding side effects and effectiveness of the vaccine. Continue Reading
-
News
21 Sep 2020
Immunotherapy Combo from Bristol Myers Squibb Improves Survival
Bristol Myers Squibb’s drug showed a four-year survival rate of 50 percent in the longest follow-up for an immunotherapy-based combination in previously untreated advanced renal cell carcinoma. Continue Reading
-
News
16 Sep 2020
Gauss, Cellex Launch First At-Home COVID-19 Antigen Test
Pending FDA approval, the at-home COVID-19 antigen test leverages a mobile app and artificial intelligence to provide a scalable, affordable testing option. Continue Reading
-
News
15 Sep 2020
J&J COVID-19 Vaccine Shows Promise in Preclinical Trial
Results from a preclinical trial show that Johnson and Johnson’s lead COVID-19 vaccine, Ad26.COV2.S, neutralized antibodies and prevented severe clinical disease in hamsters. Continue Reading
-
News
14 Sep 2020
Promoting Health Equity in COVID-19 Vaccine Clinical Trials
Traditionally marginalized populations have been disproportionately impacted by COVID-19. As vaccine clinical trials begin, researchers must ensure these populations are included to promote health equity. Continue Reading
-
News
14 Sep 2020
Systemic Corticosteroids Linked to Lower COVID-19 Mortality
The absolute mortality risk was 32 percent for COVID-19 patients treated with systemic corticosteroids, compared to a 40 percent risk for patients receiving standard care. Continue Reading
-
News
09 Sep 2020
Eli Lilly’s Diabetes Drug Jardiance Helps Heart Failure, Too
The type 2 diabetes drug, Jardiance, reduced the relative risk of first and recurrent hospitalization for heart failure by 30 percent and significantly slowed kidney function decline. Continue Reading
-
News
08 Sep 2020
CEOs Pledge to Uphold Scientific Integrity for COVID-19 Vaccine
Nine biopharmaceutical company CEOs signed a pledge ensuring safety, well-being, and scientific integrity will remain the top priority during COVID-19 vaccine development. Continue Reading
-
News
08 Sep 2020
Breaking Down the Stages of Clinical Trials, Their Challenges
Innovative drugs and therapies can significantly improve outcomes for patients, but they must first make it through the four stages of clinical trials. Continue Reading
-
News
03 Sep 2020
AstraZeneca’s COVID-19 Vaccine Enters Phase 3 Clinical Trial
The Phase 3 clinical trial will assess the safety and efficacy of the COVID-19 vaccine in nearly 30,000 adults from various geographic backgrounds, who are either healthy or have underlying conditions. Continue Reading
-
News
02 Sep 2020
GSK, Vir Dose First Patient in Phase 2/3 COVID-19 Antibody Study
The Phase 2/3 study will enroll nearly 1,300 patients worldwide to uncover if a single-dose of a COVID-19 antibody can prevent hospitalization due to the coronavirus. Continue Reading
-
News
01 Sep 2020
How EHR-Based Clinical Trials Can Accelerate Research Strategies
EHR-based clinical trials can provide a platform to enroll patients and deliver interventions, lowering the cost and enhancing the feasibility of conducting a trial, researchers said. Continue Reading
-
News
31 Aug 2020
Clinical Trial Design, Composition Has Undergone Major Changes
A recent study finds clinical trial design and composition has changed since 2000, warranting more funding for larger, randomized clinical trials. Continue Reading
-
News
28 Aug 2020
Early Positive Data for Pfizer’s mRNA COVID-19 Vaccine Candidate
Pfizer and BioNTech’s lead mRNA COVID-19 vaccine candidate elicited SARS-CoV-2-neutralizing geometric mean titers in both younger and older adults with minimal side effects. Continue Reading
-
News
28 Aug 2020
Anticoagulation Therapy Improves Outcomes for COVID-19 Patients
Researchers from Mount Sinai found that anticoagulation therapy is connected with lower intubation and a nearly 50 percent higher chance of survival among COVID-19 patients. Continue Reading
-
News
25 Aug 2020
GSK Launches Phase 3 Trial for 5-in-1 Meningitis Vaccine
If GSK’s 5-in-1 meningitis vaccine candidate succeeds in trials, fewer vaccines could be required to protect adolescents and young adults from Invasive Meningococcal Disease. Continue Reading
-
Feature
14 Aug 2020
Warp Speed COVID-19 Clinical Trials Boost Future Vaccine Development
Vaccine development is generally a time-consuming process, but the unprecedented speed of COVID-19 clinical trials will have implications across the pharmaceutical industry. Continue Reading
-
News
12 Aug 2020
Third of Americans Would Pass on COVID-19 Vaccine If Ready Today
A Gallup survey found that many Americans are unlikely to get a COVID-19 vaccine today even if it was free and approved by the FDA. Continue Reading
-
News
11 Aug 2020
Roche’s Tecentriq Fails in Phase 3 Breast Cancer Trial
Roche’s FDA approved lung cancer drug showed promise in previous breast cancer trials, but had negative trends for the primary and secondary endpoints of overall survival in a phase 3 study. Continue Reading
-
News
06 Aug 2020
Eli Lilly Launches Phase 3 Trial of COVID-19 Antibody Treatment
The study will enroll nearly 2,500 residents and staff at long-term care facilities across the USto test the efficacy of a COVID-19 antibody treatment. Continue Reading
-
News
05 Aug 2020
COVID R&D Alliance Starts Clinical Trial for Coronavirus Treatments
The I-SPY COVID-19 trial will evaluate the efficacy of potential coronavirus treatments for patients who require high-flow oxygen. Continue Reading
-
News
05 Aug 2020
Johnson & Johnson’s Single Shot COVID-19 Vaccine Helps Monkeys
The study published in Nature shows Johnson & Johnson’s investigational COVID-19 vaccine elicited a strong immune response in monkeys, prompting the company to try it on humans next. Continue Reading
-
News
03 Aug 2020
Key Strategies for Advancing Gene and Cell Therapy Development
Gene and cell therapy development has the potential to transform the pharmaceutical industry, but organizations must work together to overcome challenges down the line. Continue Reading
-
News
30 Jul 2020
Pfzier, BioNTech Select mRNA COVID-19 Vaccine Candidate
The two companies will also launch a global Phase 2/3 clinical trial to test the safety and efficacy of the mRNA COVID-19 vaccine candidate. Continue Reading
-
News
29 Jul 2020
Roche’s Arthritis Drug Fails in Phase III COVID-19 Treatment Study
The rheumatoid arthritis drug, Actemra, did not meet its primary endpoint of improved clinical status in patients with COVID-19 associated pneumonia or the key secondary endpoint of reduced patient mortality, Roche reported. Continue Reading
-
News
29 Jul 2020
Pull Funding May Combat COVID-19 Vaccine Development Challenges
A study shows that a pull funding system, rather than a push system based on direct cost reimbursement, could accelerate COVID-19 vaccine development. Continue Reading
-
News
27 Jul 2020
Direct-Acting Antiviral Lowers Mortality Rate Among HCV Patients
A JAMA study found that increasing access to direct-acting antiviral drugs for all patients with HCV, regardless of disease progression, could improve population health. Continue Reading
-
News
24 Jul 2020
Harvard Launches Spinout to Address mRNA, CRISPR Challenges
Vesigen Therapeutics will commercialize new technologies to target intracellular drug delivery, including CRISPR, mRNA, RNA, and other therapeutic proteins. Continue Reading
-
News
22 Jul 2020
Phase 3 Clinical Trial to Study Antibody for Alzheimer’s Disease
The Phase 3 clinical trial for antibody BAN2401 will uncover if initiating treatment much earlier in Alzheimer’s Disease can prevent future cognitive decline in patients. Continue Reading
-
News
21 Jul 2020
Oxford-AstraZeneca COVID-19 Vaccine Displays Immune Response
The COVID-19 vaccine being developed by Oxford University and AstraZeneca showed promising results in a Phase 1/2 clinical trial, new data shows. Continue Reading
-
News
20 Jul 2020
Eli Lilly Releases Positive Phase 3 Study Results for its Antibody
The antibody, Mirikizumab, met the primary and all key secondary endpoints versus placebo at Week 16 and all key secondary endpoints versus Cosentyx at Week 16 and Week 52. Continue Reading
-
News
20 Jul 2020
Dopamine Agonist Showed No Notable Benefit in Alzheimer’s Patients
Although dopamine agonist, rotigotine, was generally safe and well-tolerated in Alzheimer’s patients, it showed no real benefit compared to placebo, a JAMA study found. Continue Reading
-
News
17 Jul 2020
Pharma Manufacturing Industry Ranks Second in R&D Intensity
The pharmaceutical manufacturing industry devotes a larger share of its revenue in R&D, which means it is only receiving a considerably small share of total spending. Continue Reading
-
News
16 Jul 2020
Oxford Scientists Develop Spinout to Launch COVID-19 Rapid Test
The affordable COVID-19 rapid test will soon be certified with CE-mark and shortly available in quantity with the commercial product name Oxsed RiViD Direct. Continue Reading
-
News
14 Jul 2020
Gilead Releases Additional Data on COVID-19 Antiviral, Remdesivir
Data presented includes a comparative analysis of Gilead’s Phase 3 SIMPLE clinical trial and a real-world retrospective cohort of patients with severe COVID-19. Continue Reading
-
News
13 Jul 2020
GSK, Medicago, to Develop Novel Adjuvanted COVID-19 Vaccine
The collaboration will combine plant-based and adjuvant technologies to develop a COVID-19 candidate vaccine, with Phase 1 clinical testing scheduled to being mid-July. Continue Reading
-
News
30 Jun 2020
Abbott to Create Diabetes Management Solutions with Tandem
The companies will leverage Abbott's continuous glucose monitoring technology with Tandem's insulin delivery system to simplify and tailor diabetes management. Continue Reading
-
News
30 Jun 2020
ICER Raises Pricing Recommendation for COVID-19 Drug Remdesivir
The price hike comes over a month after ICER used two different pricing models and determined that the antiviral and COVID-19 drug remdesivir could be priced at $4,500. Continue Reading
-
News
25 Jun 2020
WHO Halts Hydroxychloroquine Study After Seeing No COVID-19 Benefit
WHO based its decision on an analysis showing that hydroxychloroquine showed no substantial benefit as treatment for patients hospitalized with COVID-19. Continue Reading
-
News
24 Jun 2020
Insulin, GLP-1 RA Combo Improves Blood Sugar Control for Diabetics
The combination of insulin and GLP-1RA therapies helped patients improve blood sugar levels compared to sequential addition of one injectable followed by the other, Sanofi reports. Continue Reading
-
News
22 Jun 2020
Eli Lilly Starts Phase 3 Study of RA Drug as COVID-19 Treatment
The Phase 3 clinical trial will complement an ongoing NIAID trial to further understand Eli Lilly’s baricitinib as a potential COVID-19 treatment. Continue Reading
-
News
22 Jun 2020
Phase 3 Study Finds Roche’s Acute Myeloid Leukemia Drug Effective
Venclexa combined with azacitidine reduced the risk of death in patients with acute myeloid leukemia by 34 percent compared with azacitidine alone. Continue Reading
-
News
18 Jun 2020
AstraZeneca’s Calquence Shows Improvement in Two Clinical Trials
A week after a study found Calquence helped some hospitalized COVID-19 patients, two clinical trials affirm the AstraZeneca drug benefits chronic lymphocytic leukemia patients. Continue Reading
-
News
17 Jun 2020
Steroid Dexamethasone Reduces COVID-19 Deaths, Initial Data Shows
A randomized clinical trial found that dexamethasone is the first drug proven effective against COVID-19, reducing 28-day mortality rate in one-third of patients. Continue Reading
-
News
16 Jun 2020
AstraZeneca, Accent Therapeutics to Create Novel Cancer Therapies
The companies will target RNA modifying proteins to create novel cancer therapies that will provide a new approach for addressing disruptions that could cause resistance to treatment. Continue Reading
-
News
12 Jun 2020
Phase 3 Trial Finds AbbVie’s Rheumatoid Arthritis Drug Effective
AbbVie’s RINVOQ met the primary and key secondary endpoints on change from baseline in DAS28-CRP at Week 12 in patients with moderate to severe rheumatoid arthritis. Continue Reading
-
News
11 Jun 2020
Top COVID-19 Vaccines, Treatments Moving Forward in Clinical Trials
Pharma companies have launched numerous COVID-19 vaccines and treatments over the past few months. Here are recent updates from clinical trials testing the drugs. Continue Reading
-
News
10 Jun 2020
Phase 1 Study Starts for Lilly’s Second COVID-19 Antibody Treatment
The study will evaluate efficacy of Lilly’s JS016 as a single agent and in combination with other COVID-19 antibody treatments in patients. Continue Reading
-
News
10 Jun 2020
D-cycloserine Augments Exposure Therapy for SAD, Trial Finds
A clinical trial showed that D-cycloserine can augment exposure therapy for SAD when administered before or after the session, but the findings did not support a tailored approach to administration. Continue Reading
-
News
09 Jun 2020
Clinical Trial Finds Hydroxychloroquine Does Not Prevent COVID-19
11.8% of those receiving hydroxychloroquine got COVID-19, compared with 14.3% of those receiving placebo. The absolute difference was –2.4 percentage points, the clinical trial showed. Continue Reading
-
News
09 Jun 2020
Combination Antibody Therapy Reduces Relapsed Multiple Myeloma
Sanofi’s Sarclisa combination antibody therapy demonstrated superior progression free survival and clinically meaningful depth of response in patients with relapsed multiple myeloma. Continue Reading
-
News
08 Jun 2020
Eli Lilly Launches Global Study of COVID-19 Antibody Treatments
The placebo-controlled study will assess the safety and tolerability of potential COVID-19 antibody treatments in patients hospitalized with the coronavirus. Continue Reading
-
News
08 Jun 2020
Cancer Clinical Trial Enrollment Fell During COVID-19 Pandemic
Cancer clinical trial enrollment decreased from 150 patients per week to 109 over several weeks as COVID-19 cases increased over 22,000 during that time, a JAMA study found. Continue Reading
-
News
04 Jun 2020
Moderna Doses First Patients in Phase 2 Study of COVID-19 Vaccine
Moderna will eventually enroll 600 participants in the study and evaluate the safety, reactogenicity, and immunogenicity of two COVID-19 vaccines using mRNA-1273. Continue Reading
-
News
03 Jun 2020
Gilead Reports Remdesivir Helped Moderately Ill COVID-19 Patients
A Phase 3 clinical trial found that a five-day treatment course of remdesivir resulted in significantly greater clinical improvement versus standard care alone among patients with moderate COVID-19. Continue Reading
-
News
02 Jun 2020
Antidepressant Ineffective Against Apathy in Alzheimer’s Patients
Although it is safe, bupropion was ineffective compared to a placebo for the treatment of apathy in patients with dementia of Alzheimer type, an analysis shows. Continue Reading
-
News
02 Jun 2020
GSK to Manufacture 1B Doses of COVID-19 Vaccine Adjuvant System
GSK’s COVID-19 vaccine adjuvant can reduce the amount of vaccine protein required per dose, which allows more vaccine doses to be produced, protecting more individuals. Continue Reading
-
News
01 Jun 2020
Bristol Myers Squibb Drug Ineffective for Recurrent Glioblastoma
Nearly 95 percent of recurrent glioblastoma patients treated with Bristol Myers Squibb drug, nivolumab, discontinued treatment due to disease progression. Continue Reading
-
Feature
28 May 2020
How COVID-19 Is Changing Pharmaceutical Research and Development
As the drug companies hurry to develop a coronavirus vaccine, they are also reshaping the pharmaceutical research and development landscape for the future. Continue Reading
-
News
27 May 2020
Merck and IAVI Partner to Develop Potential COVID-19 Vaccine
The companies will leverage capabilities with rVSV technology to advance the development and global clinical evaluation of the COVID-19 vaccine candidate. Continue Reading
-
News
22 May 2020
AstraZeneca Inks Deals to Supply 400M Doses of a COVID-19 Vaccine
The deals also secured total manufacturing capacity for 1 billion doses of the University of Oxford’s COVID-19 vaccine. Continue Reading
-
News
21 May 2020
Study Identifies Potential Therapeutic COVID-19 Antibody
S309, an antibody isolated from a patient who recovered from SARS in 2003, could be a potential therapeutic COVID-19 antibody, researchers found. Continue Reading
-
News
20 May 2020
GSK Touts HIV Prevention Breakthrough with Long-Acting Injection
An HIV prevention study showed long-acting injectable cabotegravir administered every two months is 69% more effective than daily pills preventing HIV. Continue Reading
-
News
18 May 2020
Positive Trial Data for Moderna’s COVID-19 Vaccine Candidate
Moderna’s vaccine candidate, mRNA-1273, was generally well-tolerated and elicited neutralizing antibodies in all eight clinical trial participants, the company reported. Continue Reading
-
News
11 May 2020
Phase 3 Trial Finds Positive Results for Microbiome Treatment
Rebiotix and Ferring Pharmaceuticals are the first to announce positive Phase 3 clinical trial results for RBX2660, a microbiome therapy treatment. Continue Reading
-
News
06 May 2020
Pfizer, BioNTech Dose First Participants in COVID-19 Vaccine Trial
The COVID-19 vaccine trial is part of a global development program that will uncover the safety and immunogenicity of four mRNA vaccine candidates. Continue Reading
-
News
05 May 2020
Pfizer, Valneva Commercialize Lyme Disease Vaccine Candidate
Valneva’s vaccine candidate, VLA15, has already completed Phase 1 clinical studies and is the only active Lyme disease vaccine program in development today. Continue Reading
-
News
05 May 2020
Janssen Advances Alveo’s At-Home COVID-19 Testing Platform
The at-home COVID-19 testing platform will enhance access to real-time results and ensure healthcare professionals make better-informed coronavirus treatment decisions. Continue Reading
-
News
01 May 2020
Lawmakers Uncover Significant Gaps in COVID-19 Antibody Testing
Some of the problems with COVID-19 antibody testing include unanswered scientific questions and lack of established guidelines before tests were released for public use. Continue Reading
-
News
30 Apr 2020
COVID-19 Clinical Trial Questions High Doses of Chloroquine
A recent COVID-19 clinical trial uncovered that higher dosages of chloroquine for critically ill coronavirus patients could lead to safety hazards and should not be used. Continue Reading
-
News
29 Apr 2020
Gilead Hints at Remdesivir’s Potential as a COVID-19 Treatment
The pharma company announced positive results from a Phase 3 clinical trial of remdesivir as a potential severe COVID-19 treatment. Continue Reading
-
News
29 Apr 2020
Gilead, Kite Ink Deal with oNKo-innate for Cancer Immunotherapies
The collaboration will leverage oNKo-innate’s expertise in natural killer cells to discover novel cancer immunotherapies. Continue Reading
-
News
27 Apr 2020
FDA Warns of Heart Rhythm Issues with Promising COVID-19 Drugs
Hydroxychloroquine and chloroquine – two potential COVID-19 drugs – are not approved by the FDA to treat coronavirus and could lead to life-threatening heart rhythm problems, FDA Commission Hahn says. Continue Reading
-
News
27 Apr 2020
Bristol Myers Squibb, Exelixis Drug Combo Helping Kidney Cancer
A two-drug combination from Bristol Myers Squibb and Exelixis improved kidney cancer survival according to Phase 3 clinical trial results. Continue Reading
-
News
24 Apr 2020
BARDA Gives $483M to Moderna for COVID-19 Vaccine Development
The fund from BARDA will boost the development of mRNA-1273 and enable large-scale production to enhance COVID-19 vaccine development, Moderna says. Continue Reading
-
News
23 Apr 2020
Early Data Shows No Benefit of Hydroxychloroquine for COVID-19
A preprint study found that hydroxychloroquine – a drug being touted as a COVID-19 treatment – did not improve outcomes for veterans hospitalized with the virus. Continue Reading
-
News
23 Apr 2020
Biogen Partners with MA Health Orgs to Launch COVID-19 Biobank
Biogen employees and other close contacts can contribute blood samples and medical data to the COVID-19 biobank to boost coronavirus treatment efforts. Continue Reading
-
News
22 Apr 2020
Pfizer, BioNTech Team Up to Advance COVID-19 Vaccine Development
Pfizer and BioNtech released additional details on COVID-19 vaccine development plans, including ways to scale-up manufacturing capacity to support global supply. Continue Reading
-
News
21 Apr 2020
Roche Launches Serology Test to Uncover COVID-19 Antibodies
The antibodies test may indicate if a person has immunity against COVID-19, inform treatment decisions, and screen essential frontline workers so they can return to work. Continue Reading
-
News
16 Apr 2020
Eli Lilly Arthritis Drug Being Tested in COVID-19 Clinical Trial
The COVID-19 clinical trial will study the safety and efficacy of baricitnib as a potential therapy for hospitalized coronavirus patients. Continue Reading
-
News
15 Apr 2020
Sanofi, GSK Partner to Develop Adjuvanted COVID-19 Vaccine
The pharmaceutical companies will combine innovative technologies to develop an adjuvanted COVID-19 vaccine, expected to enter clinical trials in late 2020. Continue Reading
-
News
10 Apr 2020
NIH Launches Clinical Trial of Hydroxychloroquine for COVID-19
NIH begins a clinical trial to evaluate the safety and effectiveness of hydroxychloroquine, one of the most promising COVID-19 drugs, according to experts. Continue Reading
-
News
09 Apr 2020
Pfizer Commits $40M in Grants to Combat COVID-19 Pandemic
The medical and charitable grant will support research, diagnostics, and treatment efforts both domestically and globally to combat the COVID-19 pandemic. Continue Reading
-
News
08 Apr 2020
Henry Ford to Study Use of Hydroxychloroquine to Prevent COVID-19
Hydroxychloroquine is a promising COVID-19 drug for ill patients, and the first large-scale study will uncover its effectiveness to protect frontline workers. Continue Reading
-
News
06 Apr 2020
4 of the Most Promising COVID-19 Vaccines In Development
Pharmaceutical companies are working to develop COVID-19 vaccines as the virus worsens each day. The following are the most promising vaccines according to experts. Continue Reading